Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28


Glial Contribution to Excitatory and Inhibitory Synapse Loss in Neurodegeneration.

Henstridge CM, Tzioras M, Paolicelli RC.

Front Cell Neurosci. 2019 Feb 26;13:63. doi: 10.3389/fncel.2019.00063. eCollection 2019. Review.


Beyond the neuron-cellular interactions early in Alzheimer disease pathogenesis.

Henstridge CM, Hyman BT, Spires-Jones TL.

Nat Rev Neurosci. 2019 Feb;20(2):94-108. doi: 10.1038/s41583-018-0113-1. Review.


Region-specific depletion of synaptic mitochondria in the brains of patients with Alzheimer's disease.

Pickett EK, Rose J, McCrory C, McKenzie CA, King D, Smith C, Gillingwater TH, Henstridge CM, Spires-Jones TL.

Acta Neuropathol. 2018 Nov;136(5):747-757. doi: 10.1007/s00401-018-1903-2. Epub 2018 Sep 6.


Modeling Alzheimer's disease brains in vitro.

Henstridge CM, Spires-Jones TL.

Nat Neurosci. 2018 Jul;21(7):899-900. doi: 10.1038/s41593-018-0177-2. No abstract available.


FENS-Kavli winter symposium: Addressing the cellular phase of dementia-visions of the UK Dementia Research Institute.

Hesse R, Henstridge CM.

Eur J Neurosci. 2018 Jul;48(2):1720-1722. doi: 10.1111/ejn.14059. Epub 2018 Jul 21. Review.


Synapse loss in the prefrontal cortex is associated with cognitive decline in amyotrophic lateral sclerosis.

Henstridge CM, Sideris DI, Carroll E, Rotariu S, Salomonsson S, Tzioras M, McKenzie CA, Smith C, von Arnim CAF, Ludolph AC, Lulé D, Leighton D, Warner J, Cleary E, Newton J, Swingler R, Chandran S, Gillingwater TH, Abrahams S, Spires-Jones TL.

Acta Neuropathol. 2018 Feb;135(2):213-226. doi: 10.1007/s00401-017-1797-4. Epub 2017 Dec 22.


Synaptic phosphorylated α-synuclein in dementia with Lewy bodies.

Colom-Cadena M, Pegueroles J, Herrmann AG, Henstridge CM, Muñoz L, Querol-Vilaseca M, Martín-Paniello CS, Luque-Cabecerans J, Clarimon J, Belbin O, Núñez-Llaves R, Blesa R, Smith C, McKenzie CA, Frosch MP, Roe A, Fortea J, Andilla J, Loza-Alvarez P, Gelpi E, Hyman BT, Spires-Jones TL, Lleó A.

Brain. 2017 Dec 1;140(12):3204-3214. doi: 10.1093/brain/awx275.


Big conductance calcium-activated potassium channel openers control spasticity without sedation.

Baker D, Pryce G, Visintin C, Sisay S, Bondarenko AI, Vanessa Ho WS, Jackson SJ, Williams TE, Al-Izki S, Sevastou I, Okuyama M, Graier WF, Stevenson LA, Tanner C, Ross R, Pertwee RG, Henstridge CM, Irving AJ, Schulman J, Powell K, Baker MD, Giovannoni G, Selwood DL.

Br J Pharmacol. 2017 Aug;174(16):2662-2681. doi: 10.1111/bph.13889. Epub 2017 Jul 7.


TDP-43 Depletion in Microglia Promotes Amyloid Clearance but Also Induces Synapse Loss.

Paolicelli RC, Jawaid A, Henstridge CM, Valeri A, Merlini M, Robinson JL, Lee EB, Rose J, Appel S, Lee VM, Trojanowski JQ, Spires-Jones T, Schulz PE, Rajendran L.

Neuron. 2017 Jul 19;95(2):297-308.e6. doi: 10.1016/j.neuron.2017.05.037. Epub 2017 Jun 29.


Spread of tau down neural circuits precedes synapse and neuronal loss in the rTgTauEC mouse model of early Alzheimer's disease.

Pickett EK, Henstridge CM, Allison E, Pitstick R, Pooler A, Wegmann S, Carlson G, Hyman BT, Spires-Jones TL.

Synapse. 2017 Jun;71(6). doi: 10.1002/syn.21965. Epub 2017 Mar 6.


Non-Fibrillar Oligomeric Amyloid-β within Synapses.

Pickett EK, Koffie RM, Wegmann S, Henstridge CM, Herrmann AG, Colom-Cadena M, Lleo A, Kay KR, Vaught M, Soberman R, Walsh DM, Hyman BT, Spires-Jones TL.

J Alzheimers Dis. 2016 May 30;53(3):787-800. doi: 10.3233/JAD-160007.


GPR55: Metabolic Help or Hindrance?

Henstridge CM, Brown AJ, Waldhoer M.

Trends Endocrinol Metab. 2016 Sep;27(9):606-608. doi: 10.1016/j.tem.2016.04.012. Epub 2016 May 21. Review.


Synaptic pathology: A shared mechanism in neurological disease.

Henstridge CM, Pickett E, Spires-Jones TL.

Ageing Res Rev. 2016 Jul;28:72-84. doi: 10.1016/j.arr.2016.04.005. Epub 2016 Apr 20. Review.


Erratum to: Post-mortem brain analyses of the Lothian Birth Cohort 1936: extending lifetime cognitive and brain phenotyping to the level of the synapse.

Henstridge CM, Jackson RJ, Kim JM, Herrmann AG, Wright AK, Harris SE, Bastin ME, Starr JM, Wardlaw J, Gillingwater TH, Smith C, McKenzie CA, Cox SR, Deary IJ, Spires-Jones TL.

Acta Neuropathol Commun. 2015 Dec 9;3(1):83. doi: 10.1186/s40478-015-0244-9.


Post-mortem brain analyses of the Lothian Birth Cohort 1936: extending lifetime cognitive and brain phenotyping to the level of the synapse.

Henstridge CM, Jackson RJ, Kim JM, Herrmann AG, Wright AK, Harris SE, Bastin ME, Starr JM, Wardlaw J, Gillingwater TH, Smith C, McKenzie CA, Cox SR, Deary IJ, Spires-Jones TL.

Acta Neuropathol Commun. 2015 Sep 4;3:53. doi: 10.1186/s40478-015-0232-0. Erratum in: Acta Neuropathol Commun. 2015;3(1):83.


Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release.

Lee SH, Ledri M, Tóth B, Marchionni I, Henstridge CM, Dudok B, Kenesei K, Barna L, Szabó SI, Renkecz T, Oberoi M, Watanabe M, Limoli CL, Horvai G, Soltesz I, Katona I.

J Neurosci. 2015 Jul 8;35(27):10039-57. doi: 10.1523/JNEUROSCI.4112-14.2015.


Functional and structural deficits at accumbens synapses in a mouse model of Fragile X.

Neuhofer D, Henstridge CM, Dudok B, Sepers M, Lassalle O, Katona I, Manzoni OJ.

Front Cell Neurosci. 2015 Mar 26;9:100. doi: 10.3389/fncel.2015.00100. eCollection 2015.


Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling.

Dudok B, Barna L, Ledri M, Szabó SI, Szabadits E, Pintér B, Woodhams SG, Henstridge CM, Balla GY, Nyilas R, Varga C, Lee SH, Matolcsi M, Cervenak J, Kacskovics I, Watanabe M, Sagheddu C, Melis M, Pistis M, Soltesz I, Katona I.

Nat Neurosci. 2015 Jan;18(1):75-86. doi: 10.1038/nn.3892. Epub 2014 Dec 8.


Heterogeneous presynaptic distribution of monoacylglycerol lipase, a multipotent regulator of nociceptive circuits in the mouse spinal cord.

Horváth E, Woodhams SG, Nyilas R, Henstridge CM, Kano M, Sakimura K, Watanabe M, Katona I.

Eur J Neurosci. 2014 Feb;39(3):419-34. doi: 10.1111/ejn.12470.


Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome.

Jung KM, Sepers M, Henstridge CM, Lassalle O, Neuhofer D, Martin H, Ginger M, Frick A, DiPatrizio NV, Mackie K, Katona I, Piomelli D, Manzoni OJ.

Nat Commun. 2012;3:1080. doi: 10.1038/ncomms2045.


Off-target cannabinoid effects mediated by GPR55.

Henstridge CM.

Pharmacology. 2012;89(3-4):179-87. doi: 10.1159/000336872. Epub 2012 Mar 16. Review.


Minireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55.

Henstridge CM, Balenga NA, Kargl J, Andradas C, Brown AJ, Irving A, Sanchez C, Waldhoer M.

Mol Endocrinol. 2011 Nov;25(11):1835-48. doi: 10.1210/me.2011-1197. Epub 2011 Sep 29. Review.


Pharmacology, signaling and physiological relevance of the G protein-coupled receptor 55.

Balenga NA, Henstridge CM, Kargl J, Waldhoer M.

Adv Pharmacol. 2011;62:251-77. doi: 10.1016/B978-0-12-385952-5.00004-X. Review.


GPR55 ligands promote receptor coupling to multiple signalling pathways.

Henstridge CM, Balenga NA, Schröder R, Kargl JK, Platzer W, Martini L, Arthur S, Penman J, Whistler JL, Kostenis E, Waldhoer M, Irving AJ.

Br J Pharmacol. 2010 Jun;160(3):604-14. doi: 10.1111/j.1476-5381.2009.00625.x. Epub 2010 Feb 5.


Fluorescent ligand binding reveals heterogeneous distribution of adrenoceptors and 'cannabinoid-like' receptors in small arteries.

Daly CJ, Ross RA, Whyte J, Henstridge CM, Irving AJ, McGrath JC.

Br J Pharmacol. 2010 Feb;159(4):787-96. doi: 10.1111/j.1476-5381.2009.00608.x. Epub 2010 Feb 5.


The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation.

Henstridge CM, Balenga NA, Ford LA, Ross RA, Waldhoer M, Irving AJ.

FASEB J. 2009 Jan;23(1):183-93. doi: 10.1096/fj.08-108670. Epub 2008 Aug 29.


Generation and functional characterization of fluorescent, N-terminally tagged CB1 receptor chimeras for live-cell imaging.

McDonald NA, Henstridge CM, Connolly CN, Irving AJ.

Mol Cell Neurosci. 2007 Jun;35(2):237-48. Epub 2007 Mar 3.


An essential role for constitutive endocytosis, but not activity, in the axonal targeting of the CB1 cannabinoid receptor.

McDonald NA, Henstridge CM, Connolly CN, Irving AJ.

Mol Pharmacol. 2007 Apr;71(4):976-84. Epub 2006 Dec 20.


Supplemental Content

Loading ...
Support Center